SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001683168-17-002887
Filing Date
2017-11-09
Accepted
2017-11-09 16:25:10
Documents
15
Period of Report
2017-11-09
Items
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT sonoma_8k-110917.htm 8-K 55434
2 PRESS RELEASE sonoma_ex9901.htm EX-99.1 123023
3 GRAPHIC image_001.jpg GRAPHIC 3702
4 PRESENTATION sonoma_ex9902.htm EX-99.2 15136
5 GRAPHIC image_002.jpg GRAPHIC 146986
6 GRAPHIC image_003.jpg GRAPHIC 79882
7 GRAPHIC image_004.jpg GRAPHIC 138169
8 GRAPHIC image_005.jpg GRAPHIC 75024
9 GRAPHIC image_006.jpg GRAPHIC 70560
10 GRAPHIC image_007.jpg GRAPHIC 117682
11 GRAPHIC image_008.jpg GRAPHIC 85265
12 GRAPHIC image_009.jpg GRAPHIC 98416
13 GRAPHIC image_010.jpg GRAPHIC 59550
14 GRAPHIC image_011.jpg GRAPHIC 80516
15 GRAPHIC image_012.jpg GRAPHIC 109678
  Complete submission text file 0001683168-17-002887.txt   1663794
Mailing Address 1129 N. MCDOWELL BLVD. PETALUMA CA 94954
Business Address 1129 N. MCDOWELL BLVD. PETALUMA CA 94954 707-283-0550
Sonoma Pharmaceuticals, Inc. (Filer) CIK: 0001367083 (see all company filings)

IRS No.: 680423298 | State of Incorp.: DE | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-33216 | Film No.: 171191199
SIC: 2834 Pharmaceutical Preparations